Fortress Biotech, Inc. engages in the manufacture and commercialization of novel pharmaceutical products and product candidates. The company is headquartered in Bay Harbor Islands, Florida and currently employs 101 full-time employees. The company went IPO on 2011-11-17. The firm has eight marketed prescription pharmaceutical products and over 20 programs in development, with its majority-owned and majority-controlled partners and subsidiaries and partners and subsidiaries it founded and in which it holds significant minority ownership positions. Its portfolio is being commercialized and developed for various therapeutic areas, including oncology, dermatology, and rare diseases. Its dermatology products include Emrosi, Qbrexza, Amzeeq, Zilxi, Exelderm, Targadox, and Luxamend. Its late-stage product candidates include CUTX-101 (copper histidinate injection for Menkes disease), Triplex (cytomegalovirus (CMV) vaccine), and CAEL-101 (monoclonal antibody for AL amyloidosis). Its early and mid-stage product candidates include Dotinurad (urate transporter (URAT1) inhibitor for gout), MB-101 (IL13Rα2 CAR T Cell Program for Glioblastoma), and others.
Fortress Biotech Inc tiene un dividendo anual de 0.2191 por acción, con un rendimiento del 0.6043%. El dividendo se paga mensualmente y la última fecha ex-dividendo fue Jun 14, 2024.
Rendimiento de dividendos
Dividendo anual
Fecha de ex-dividendos
0.6043%
$0.2191
Jun 14, 2024
Frecuencia de pago
Relación de pago
Mensualmente
0.00%
Historial de dividendos
Fecha de ex-dividendos
Monto en efectivo
Fecha de Registro
Fecha de Pago
Jun 14, 2024
$0.1953
Jun 15, 2024
Jun 30, 2024
May 14, 2024
$0.1953
May 15, 2024
May 31, 2024
Apr 12, 2024
$0.1953
Apr 15, 2024
Apr 30, 2024
Mar 14, 2024
$0.1953
Mar 15, 2024
Mar 31, 2024
Feb 14, 2024
$0.1953
Feb 15, 2024
Feb 29, 2024
Jan 11, 2024
$0.1953
Jan 15, 2024
Jan 31, 2024
Gráficos de dividendos
FBIOP Dividendos
FBIOP Crecimiento de Dividendos (YoY)
Follow-Up Questions
¿Cuál es el dividendo actual pagado por Fortress Biotech Inc y su dividendo anual?
¿Cuál es el ratio de pago de dividendos de Fortress Biotech Inc?